Polymyalgia rheumatica and giant cell arteritis.
Polymyalgia rheumatica and giant cell arteritis are the commonest inflammatory rheumatic conditions seen in the elderly. This review focuses on the diagnostic processes and complications of disease and treatment; and the safe management of these conditions with careful consideration of balance between benefits and long-term risks of glucocorticosteroid therapy.
Subrahmanyan
Peddasomayajula
P
Southend Associate University Hospital NHS Trust, Essex.
Dasgupta
Bhaskar
B
D000368:Aged; D005260:Female; D013700:Giant Cell Arteritis / Q000175:diagnosis* / Q000188:drug therapy; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced; D011111:Polymyalgia Rheumatica / Q000175:diagnosis* / Q000188:drug therapy; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D012307:Risk Factors
D005938:Glucocorticoids; D011239:Prednisolone